HashiCorp (HCP)
(Delayed Data from NSDQ)
$33.80 USD
0.00 (0.00%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $33.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Earnings News For HCP
-
HashiCorp Announces Second Quarter of Fiscal Year 2025 Financial Results
-
HashiCorp to Announce Second Quarter Fiscal Year 2025 Financial Results on August 29, 2024
-
HashiCorp Announces First Quarter of Fiscal Year 2025 Financial Results
-
HashiCorp, Inc. (HCP) Beats Q1 Earnings and Revenue Estimates
-
HashiCorp, Inc. (HCP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
HashiCorp to Announce First Quarter Fiscal Year 2025 Financial Results on May 30, 2024
-
HashiCorp Announces Fourth Quarter and Fiscal Year 2024 Financial Results
-
HashiCorp to announce fourth quarter and fiscal year 2024 financial results Mar. 5, 2024
-
HashiCorp, Inc. (HCP) Beats Q3 Earnings and Revenue Estimates
-
HashiCorp Announces Third Quarter of Fiscal Year 2024 Financial Results
-
HashiCorp to announce third quarter fiscal year 2024 financial results Dec. 7, 2023
-
HashiCorp, Inc. (HCP) Reports Q2 Loss, Tops Revenue Estimates
-
HashiCorp Announces Second Quarter of Fiscal Year 2024 Financial Results
-
HashiCorp to announce second quarter fiscal year 2024 financial results Aug. 31, 2023
-
HashiCorp, Inc. (HCP) Reports Q1 Loss, Tops Revenue Estimates
-
HashiCorp Announces First Quarter Financial Results of Fiscal Year 2024
-
HashiCorp to Announce First Quarter Fiscal Year 2024 Financial Results June 7, 2023
-
HashiCorp, Inc. (HCP) Reports Q4 Loss, Tops Revenue Estimates
-
HashiCorp Announces Fourth Quarter and Fiscal Year 2023 Financial Results
-
HashiCorp to Announce Fourth Quarter and Fiscal Year 2023 Financial Results March 9, 2023
-
HashiCorp Announces Third Quarter Financial Results of Fiscal Year 2023
-
HashiCorp to Announce Third Quarter Fiscal 2023 Financial Results Dec. 7, 2022
-
HCP (HCP) Q3 FFO and Revenues Surpass Estimates
-
HCP (HCP) Q2 FFO and Revenues Beat Estimates
-
Key Factors Setting the Tone for HCP This Earnings Season